$ONMD SEC Filings

As previously disclosed, on April 14, 2026, OneMedNet Corporation (the “Company”) received a letter from the staff of the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it...

Bought 129,758 shares ($750K)

Bought 45,126 shares ($250K)

Received 65,000 shares as a grant or award · Sold 5,000 shares ($37K) · Sold 1,667 shares ($10.8K)

Received 10,000 shares as a grant or award · Received 35,000 shares as a grant or award · Sold 2,500 shares ($16.5K) · 2 more

MINNEAPOLIS, Minn.– September 25, 2026– OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announ...

1. Purpose. The purpose of the OneMedNet Corporation Amended and Restated 2022 Equity Incentive Plan (the “Plan”) is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a me...

Bought 142,857 shares ($90K)

Bought 1,449,275 shares ($1M)